nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—CYP11B2—Spironolactone—dilated cardiomyopathy	0.53	0.606	CbGbCtD
Metoclopramide—CYP11B1—Spironolactone—dilated cardiomyopathy	0.344	0.394	CbGbCtD
Metoclopramide—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.00402	0.0709	CcSEcCtD
Metoclopramide—Incontinence—Furosemide—dilated cardiomyopathy	0.00347	0.0611	CcSEcCtD
Metoclopramide—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.00343	0.0605	CcSEcCtD
Metoclopramide—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00253	0.0447	CcSEcCtD
Metoclopramide—Cinchocaine—SCN5A—dilated cardiomyopathy	0.00221	0.388	CrCbGaD
Metoclopramide—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00199	0.0351	CcSEcCtD
Metoclopramide—Sunitinib—RPS6KB1—dilated cardiomyopathy	0.00168	0.295	CrCbGaD
Metoclopramide—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.00142	0.025	CcSEcCtD
Metoclopramide—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00129	0.0227	CcSEcCtD
Metoclopramide—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00125	0.022	CcSEcCtD
Metoclopramide—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00119	0.0209	CcSEcCtD
Metoclopramide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00116	0.0205	CcSEcCtD
Metoclopramide—Procainamide—SCN5A—dilated cardiomyopathy	0.00114	0.201	CrCbGaD
Metoclopramide—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000935	0.0165	CcSEcCtD
Metoclopramide—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000909	0.016	CcSEcCtD
Metoclopramide—Wheezing—Lisinopril—dilated cardiomyopathy	0.000882	0.0156	CcSEcCtD
Metoclopramide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000871	0.0154	CcSEcCtD
Metoclopramide—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000863	0.0152	CcSEcCtD
Metoclopramide—Confusional state—Spironolactone—dilated cardiomyopathy	0.000801	0.0141	CcSEcCtD
Metoclopramide—Somnolence—Spironolactone—dilated cardiomyopathy	0.000706	0.0124	CcSEcCtD
Metoclopramide—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000702	0.0124	CcSEcCtD
Metoclopramide—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000696	0.0123	CcSEcCtD
Metoclopramide—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000693	0.0122	CcSEcCtD
Metoclopramide—Drowsiness—Furosemide—dilated cardiomyopathy	0.000677	0.0119	CcSEcCtD
Metoclopramide—Procainamide—SLC22A5—dilated cardiomyopathy	0.000658	0.116	CrCbGaD
Metoclopramide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000654	0.0115	CcSEcCtD
Metoclopramide—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000632	0.0111	CcSEcCtD
Metoclopramide—Urticaria—Spironolactone—dilated cardiomyopathy	0.000631	0.0111	CcSEcCtD
Metoclopramide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000628	0.0111	CcSEcCtD
Metoclopramide—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000627	0.0111	CcSEcCtD
Metoclopramide—Visual impairment—Furosemide—dilated cardiomyopathy	0.000586	0.0103	CcSEcCtD
Metoclopramide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000585	0.0103	CcSEcCtD
Metoclopramide—Asthma—Lisinopril—dilated cardiomyopathy	0.00057	0.0101	CcSEcCtD
Metoclopramide—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000561	0.00989	CcSEcCtD
Metoclopramide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000543	0.00958	CcSEcCtD
Metoclopramide—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000533	0.0094	CcSEcCtD
Metoclopramide—Dizziness—Spironolactone—dilated cardiomyopathy	0.000525	0.00926	CcSEcCtD
Metoclopramide—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000525	0.00926	CcSEcCtD
Metoclopramide—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000509	0.00897	CcSEcCtD
Metoclopramide—Depression—Lisinopril—dilated cardiomyopathy	0.000507	0.00894	CcSEcCtD
Metoclopramide—Rash—Spironolactone—dilated cardiomyopathy	0.000501	0.00883	CcSEcCtD
Metoclopramide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0005	0.00882	CcSEcCtD
Metoclopramide—Headache—Spironolactone—dilated cardiomyopathy	0.000497	0.00877	CcSEcCtD
Metoclopramide—Jaundice—Lisinopril—dilated cardiomyopathy	0.000495	0.00874	CcSEcCtD
Metoclopramide—Agitation—Furosemide—dilated cardiomyopathy	0.000486	0.00858	CcSEcCtD
Metoclopramide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000474	0.00836	CcSEcCtD
Metoclopramide—Leukopenia—Furosemide—dilated cardiomyopathy	0.000474	0.00836	CcSEcCtD
Metoclopramide—Nausea—Spironolactone—dilated cardiomyopathy	0.000472	0.00832	CcSEcCtD
Metoclopramide—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000464	0.00819	CcSEcCtD
Metoclopramide—Hallucination—Lisinopril—dilated cardiomyopathy	0.000454	0.00801	CcSEcCtD
Metoclopramide—Confusional state—Furosemide—dilated cardiomyopathy	0.000436	0.00768	CcSEcCtD
Metoclopramide—Flushing—Lisinopril—dilated cardiomyopathy	0.000423	0.00747	CcSEcCtD
Metoclopramide—Hypotension—Furosemide—dilated cardiomyopathy	0.000404	0.00712	CcSEcCtD
Metoclopramide—Nervousness—Lisinopril—dilated cardiomyopathy	0.000386	0.0068	CcSEcCtD
Metoclopramide—Somnolence—Furosemide—dilated cardiomyopathy	0.000384	0.00677	CcSEcCtD
Metoclopramide—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000382	0.00673	CcSEcCtD
Metoclopramide—Fatigue—Furosemide—dilated cardiomyopathy	0.000372	0.00657	CcSEcCtD
Metoclopramide—Tremor—Lisinopril—dilated cardiomyopathy	0.000372	0.00656	CcSEcCtD
Metoclopramide—Angioedema—Lisinopril—dilated cardiomyopathy	0.000363	0.0064	CcSEcCtD
Metoclopramide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000356	0.00628	CcSEcCtD
Metoclopramide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000356	0.00627	CcSEcCtD
Metoclopramide—Palpitations—Lisinopril—dilated cardiomyopathy	0.000351	0.00619	CcSEcCtD
Metoclopramide—Urticaria—Furosemide—dilated cardiomyopathy	0.000343	0.00605	CcSEcCtD
Metoclopramide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000342	0.00602	CcSEcCtD
Metoclopramide—Anxiety—Lisinopril—dilated cardiomyopathy	0.000337	0.00594	CcSEcCtD
Metoclopramide—Confusional state—Lisinopril—dilated cardiomyopathy	0.000327	0.00576	CcSEcCtD
Metoclopramide—Oedema—Lisinopril—dilated cardiomyopathy	0.000324	0.00572	CcSEcCtD
Metoclopramide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000318	0.00561	CcSEcCtD
Metoclopramide—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000316	0.00558	CcSEcCtD
Metoclopramide—Asthenia—Furosemide—dilated cardiomyopathy	0.00031	0.00547	CcSEcCtD
Metoclopramide—Hypotension—Lisinopril—dilated cardiomyopathy	0.000303	0.00534	CcSEcCtD
Metoclopramide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000296	0.00521	CcSEcCtD
Metoclopramide—Insomnia—Lisinopril—dilated cardiomyopathy	0.000293	0.00517	CcSEcCtD
Metoclopramide—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000289	0.0051	CcSEcCtD
Metoclopramide—Somnolence—Lisinopril—dilated cardiomyopathy	0.000288	0.00508	CcSEcCtD
Metoclopramide—Dizziness—Furosemide—dilated cardiomyopathy	0.000286	0.00504	CcSEcCtD
Metoclopramide—Fatigue—Lisinopril—dilated cardiomyopathy	0.000279	0.00493	CcSEcCtD
Metoclopramide—Rash—Furosemide—dilated cardiomyopathy	0.000272	0.0048	CcSEcCtD
Metoclopramide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000272	0.0048	CcSEcCtD
Metoclopramide—Headache—Furosemide—dilated cardiomyopathy	0.000271	0.00477	CcSEcCtD
Metoclopramide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000267	0.00471	CcSEcCtD
Metoclopramide—Urticaria—Lisinopril—dilated cardiomyopathy	0.000258	0.00454	CcSEcCtD
Metoclopramide—Nausea—Furosemide—dilated cardiomyopathy	0.000257	0.00453	CcSEcCtD
Metoclopramide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000256	0.00452	CcSEcCtD
Metoclopramide—HTR4—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000251	0.00394	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000251	0.00394	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000251	0.00393	CbGpPWpGaD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000245	0.00384	CbGpPWpGaD
Metoclopramide—HTR4—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00024	0.00378	CbGpPWpGaD
Metoclopramide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000239	0.00421	CcSEcCtD
Metoclopramide—DRD3—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.000236	0.0037	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000233	0.00366	CbGpPWpGaD
Metoclopramide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000233	0.0041	CcSEcCtD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.000229	0.0036	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000226	0.00355	CbGpPWpGaD
Metoclopramide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000222	0.00391	CcSEcCtD
Metoclopramide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000214	0.00378	CcSEcCtD
Metoclopramide—CYP11B1—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.000212	0.00334	CbGpPWpGaD
Metoclopramide—Rash—Lisinopril—dilated cardiomyopathy	0.000204	0.0036	CcSEcCtD
Metoclopramide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000204	0.0036	CcSEcCtD
Metoclopramide—Headache—Lisinopril—dilated cardiomyopathy	0.000203	0.00358	CcSEcCtD
Metoclopramide—HTR4—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000193	0.00303	CbGpPWpGaD
Metoclopramide—Nausea—Lisinopril—dilated cardiomyopathy	0.000193	0.0034	CcSEcCtD
Metoclopramide—HTR4—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000183	0.00288	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000182	0.00285	CbGpPWpGaD
Metoclopramide—HTR4—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000178	0.0028	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—TAZ—dilated cardiomyopathy	0.000171	0.00268	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000157	0.00246	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—SDHA—dilated cardiomyopathy	0.000155	0.00243	CbGpPWpGaD
Metoclopramide—HTR3A—Ion channel transport—RAF1—dilated cardiomyopathy	0.000153	0.00241	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000151	0.00238	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000151	0.00238	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—TAZ—dilated cardiomyopathy	0.000147	0.00231	CbGpPWpGaD
Metoclopramide—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000147	0.00231	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000147	0.0023	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000142	0.00223	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000142	0.00223	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000141	0.00221	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00014	0.00221	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—TAZ—dilated cardiomyopathy	0.000138	0.00216	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000136	0.00213	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—SDHA—dilated cardiomyopathy	0.000133	0.00209	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000132	0.00207	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000131	0.00205	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000129	0.00202	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000129	0.00202	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000128	0.00201	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000126	0.00199	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—SDHA—dilated cardiomyopathy	0.000125	0.00196	CbGpPWpGaD
Metoclopramide—CHRM1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000121	0.00191	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00012	0.00189	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00012	0.00189	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00012	0.00188	CbGpPWpGaD
Metoclopramide—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000119	0.00187	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000116	0.00182	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000116	0.00182	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000116	0.00182	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000112	0.00176	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000109	0.00171	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000108	0.0017	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000108	0.0017	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000108	0.00169	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000108	0.00169	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000105	0.00165	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000105	0.00164	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000103	0.00162	CbGpPWpGaD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000103	0.00162	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000102	0.00161	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.99e-05	0.00157	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—FAS—dilated cardiomyopathy	9.91e-05	0.00156	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.91e-05	0.00156	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.78e-05	0.00154	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	9.68e-05	0.00152	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	9.47e-05	0.00149	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.43e-05	0.00148	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.4e-05	0.00148	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	9.36e-05	0.00147	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	9.26e-05	0.00145	CbGpPWpGaD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	9.24e-05	0.00145	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	9.21e-05	0.00145	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	9.21e-05	0.00145	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.18e-05	0.00144	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	9.17e-05	0.00144	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	9.17e-05	0.00144	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	9.01e-05	0.00142	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	9.01e-05	0.00142	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	8.78e-05	0.00138	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.57e-05	0.00135	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	8.56e-05	0.00134	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	8.52e-05	0.00134	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	8.38e-05	0.00132	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	8.29e-05	0.0013	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.27e-05	0.0013	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	8.27e-05	0.0013	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	8.25e-05	0.0013	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—AGT—dilated cardiomyopathy	8.19e-05	0.00129	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.13e-05	0.00128	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	8.12e-05	0.00127	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	8.09e-05	0.00127	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.03e-05	0.00126	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.91e-05	0.00124	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.84e-05	0.00123	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.68e-05	0.00121	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.68e-05	0.00121	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.61e-05	0.00119	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.61e-05	0.00119	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.6e-05	0.00119	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—FAS—dilated cardiomyopathy	7.58e-05	0.00119	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	7.42e-05	0.00117	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.4e-05	0.00116	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	7.37e-05	0.00116	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.3e-05	0.00115	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.13e-05	0.00112	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	7.08e-05	0.00111	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.07e-05	0.00111	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	7.05e-05	0.00111	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	7.01e-05	0.0011	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	7.01e-05	0.0011	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—AGT—dilated cardiomyopathy	6.97e-05	0.00109	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.93e-05	0.00109	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.86e-05	0.00108	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.86e-05	0.00108	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.85e-05	0.00108	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.72e-05	0.00106	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	6.69e-05	0.00105	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.66e-05	0.00105	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	6.59e-05	0.00103	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.58e-05	0.00103	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.52e-05	0.00102	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	6.51e-05	0.00102	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.38e-05	0.001	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	6.32e-05	0.000992	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	6.27e-05	0.000984	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	6.18e-05	0.000971	CbGpPWpGaD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	6.13e-05	0.000963	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.85e-05	0.000919	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.55e-05	0.000872	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.39e-05	0.000847	CbGpPWpGaD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.34e-05	0.000839	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.28e-05	0.000829	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	5.18e-05	0.000813	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	5.18e-05	0.000813	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	5.12e-05	0.000803	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	5.01e-05	0.000786	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.98e-05	0.000783	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—AGT—dilated cardiomyopathy	4.96e-05	0.000779	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.88e-05	0.000766	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.84e-05	0.00076	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.82e-05	0.000756	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.77e-05	0.000749	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.7e-05	0.000739	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.7e-05	0.000739	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.66e-05	0.000732	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	4.57e-05	0.000718	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.37e-05	0.000687	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—RAC1—dilated cardiomyopathy	4.31e-05	0.000677	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.24e-05	0.000665	CbGpPWpGaD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	4.2e-05	0.00066	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GPX1—dilated cardiomyopathy	4.2e-05	0.000659	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—AGT—dilated cardiomyopathy	4.12e-05	0.000647	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—CD36—dilated cardiomyopathy	4.09e-05	0.000642	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.98e-05	0.000625	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.96e-05	0.000622	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.96e-05	0.000622	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	3.96e-05	0.000622	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.88e-05	0.000609	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.88e-05	0.000609	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—AGT—dilated cardiomyopathy	3.8e-05	0.000596	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.78e-05	0.000593	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	3.73e-05	0.000585	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	3.71e-05	0.000583	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.68e-05	0.000579	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—AGT—dilated cardiomyopathy	3.68e-05	0.000578	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GPX1—dilated cardiomyopathy	3.62e-05	0.000568	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.62e-05	0.000568	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.61e-05	0.000566	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.6e-05	0.000565	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.6e-05	0.000565	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.57e-05	0.00056	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CD36—dilated cardiomyopathy	3.52e-05	0.000553	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.52e-05	0.000553	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.52e-05	0.000553	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.49e-05	0.000548	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.43e-05	0.000539	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GPX1—dilated cardiomyopathy	3.38e-05	0.000532	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	3.37e-05	0.000529	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.35e-05	0.000525	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.32e-05	0.000521	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CD36—dilated cardiomyopathy	3.3e-05	0.000518	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.27e-05	0.000514	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.24e-05	0.000509	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—AGT—dilated cardiomyopathy	3.17e-05	0.000498	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.17e-05	0.000498	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	3.13e-05	0.000492	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.13e-05	0.000491	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.05e-05	0.000479	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.98e-05	0.000468	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—AGT—dilated cardiomyopathy	2.97e-05	0.000466	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.93e-05	0.000461	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.89e-05	0.000454	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—RAF1—dilated cardiomyopathy	2.86e-05	0.000449	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.83e-05	0.000444	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.8e-05	0.00044	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.78e-05	0.000436	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.78e-05	0.000436	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.77e-05	0.000435	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.71e-05	0.000425	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.66e-05	0.000418	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.63e-05	0.000412	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.58e-05	0.000406	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.57e-05	0.000404	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—AGT—dilated cardiomyopathy	2.55e-05	0.0004	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.5e-05	0.000393	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.39e-05	0.000376	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.34e-05	0.000368	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.24e-05	0.000353	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.2e-05	0.000345	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.14e-05	0.000337	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.14e-05	0.000336	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.13e-05	0.000334	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.13e-05	0.000334	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.1e-05	0.00033	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.08e-05	0.000327	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.08e-05	0.000327	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.04e-05	0.00032	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.03e-05	0.000318	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2e-05	0.000313	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.98e-05	0.00031	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—EGFR—dilated cardiomyopathy	1.96e-05	0.000308	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.95e-05	0.000306	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.93e-05	0.000304	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.91e-05	0.000301	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.91e-05	0.000299	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.87e-05	0.000294	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.77e-05	0.000277	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.74e-05	0.000274	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.64e-05	0.000257	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.6e-05	0.000251	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.57e-05	0.000247	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.55e-05	0.000244	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.52e-05	0.000238	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	1.5e-05	0.000236	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.35e-05	0.000212	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.33e-05	0.000209	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.32e-05	0.000208	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.3e-05	0.000205	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.21e-05	0.00019	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.2e-05	0.000189	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.18e-05	0.000185	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	1.15e-05	0.000181	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	1.13e-05	0.000177	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.04e-05	0.000164	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.27e-06	0.000146	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	9.15e-06	0.000144	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.07e-06	0.000142	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	8.91e-06	0.00014	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	8.03e-06	0.000126	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.98e-06	0.000125	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.81e-06	0.000123	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	7.16e-06	0.000112	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	5.48e-06	8.6e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.36e-06	8.42e-05	CbGpPWpGaD
